相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocystin/80K-H inhibits replication of hepatitis B virus through interaction with HBx protein in hepatoma cell
Gu-Choul Shin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Characterization of the Dynamics of Hepatitis B Virus Resistance to Adefovir by Ultra-Deep Pyrosequencing
Christophe Rodriguez et al.
HEPATOLOGY (2013)
Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus Pre-S2 mutants and its implication in hepatocarcinogenesis
Lily Hui-Ching Wang et al.
CARCINOGENESIS (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Selection of chronic hepatitis B therapy with high barrier to resistance
Robert Gish et al.
LANCET INFECTIOUS DISEASES (2012)
Biological characteristics of the rtA181T/sW172*mutant strain of Hepatitis B virus in animal model
Jie Dai et al.
VIROLOGY JOURNAL (2012)
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
CLINICAL AND MOLECULAR HEPATOLOGY (2012)
Emergence of the rtA181T/sW172*mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B
Chau-Ting Yeh et al.
BMC CANCER (2011)
Endoplasmic reticulum stress in liver disease
Harmeet Malhi et al.
JOURNAL OF HEPATOLOGY (2011)
Clinical and Virological Effects of Long-Term (Over 5 Years) Lamivudine Therapy
Yoshimasa Hashimoto et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Identification and Characterization of Clevudine-Resistant Mutants of Hepatitis B Virus Isolated from Chronic Hepatitis B Patients
So Young Kwon et al.
JOURNAL OF VIROLOGY (2010)
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Fabien Zoulim et al.
GASTROENTEROLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Susceptibility of Hepatitis B Virus to Lamivudine Restored by Resistance to Adefovir
H. L. Zaaijer et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: A retrospective, multicenter, nonrandomized, open-label study
Adriano M. Pellicelli et al.
CLINICAL THERAPEUTICS (2008)
The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound
Nadia Warner et al.
HEPATOLOGY (2008)
Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine
Silvia Gala et al.
JOURNAL OF HEPATOLOGY (2008)
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure
Stephanie Villet et al.
JOURNAL OF HEPATOLOGY (2008)
Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir
Maria Curtis et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Low resistance to adefovir combined with lamivudine: A 3-year study of 145 lamivudine-resistant hepatitis B patients
Pie-Fro Lampertico et al.
GASTROENTEROLOGY (2007)
The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro
Nadia Warner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B
Byung Chul Yoo et al.
HEPATOLOGY (2007)
Management of hepatitis B: Summary of a clinical research workshop
Jay H. Hoofnagle et al.
HEPATOLOGY (2007)
Evolution of multi-drug resistant hepatitis B virus during sequential therapy
Hyung Joon Yim et al.
HEPATOLOGY (2006)
Brief report: Variant of hepatitis B virus with primary resistance to adefovir
O Schildgen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cellular and virological mechanisms of HBV drug resistance
S Locarnini et al.
JOURNAL OF HEPATOLOGY (2006)
Virologic response and resistance to adefovir in patients with chronic hepatitis B
SK Fung et al.
JOURNAL OF HEPATOLOGY (2006)
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
Yoon-Seon Lee et al.
HEPATOLOGY (2006)
Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region
M Natsuizaka et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Chronic hepatitis B: Update of recommendations
ASF Lok et al.
HEPATOLOGY (2004)
Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus
R Perrillo et al.
GASTROENTEROLOGY (2004)
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
MG Peters et al.
GASTROENTEROLOGY (2004)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
SJ Hadziyannis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
